id	sid	eid	entity	type
admet-514	1	1	10.5599/admet.514	QUANTITY
admet-514	1	2	258	CARDINAL
admet-514	1	3	admet &	ORG
admet-514	1	4	6(3	CARDINAL
admet-514	1	5	2018	DATE
admet-514	1	6	258	CARDINAL
admet-514	1	7	issn	PERSON
admet-514	1	8	1848-7718	DATE
admet-514	1	9	richard j. honeywell*	PERSON
admet-514	1	10	sarina m. hitzerd	PERSON
admet-514	1	11	kathmann	ORG
admet-514	1	12	j. peters	ORG
admet-514	1	13	7057	DATE
admet-514	1	14	amsterdam	GPE
admet-514	2	1	netherlands	GPE
admet-514	2	2	march 06, 2018	DATE
admet-514	2	3	may 21, 2018	DATE
admet-514	2	4	july 16, 2018	DATE
admet-514	5	1	four	CARDINAL
admet-514	6	1	98-100 %	PERCENT
admet-514	7	1	2 hours	TIME
admet-514	7	2	58 %	PERCENT
admet-514	7	3	42 %	PERCENT
admet-514	8	1	crizotinib	PERSON
admet-514	8	2	alk-eml4	ORG
admet-514	10	1	39 %	PERCENT
admet-514	10	2	44 %	PERCENT
admet-514	11	1	sorafenib	PERSON
admet-514	11	2	fraction (85 %	PERCENT
admet-514	11	3	15 %	PERCENT
admet-514	11	4	2 hours	TIME
admet-514	11	5	24 hours	TIME
admet-514	11	6	9.9 fold	CARDINAL
admet-514	12	1	dasatinib	PERSON
admet-514	12	2	bcr-abl	ORG
admet-514	12	3	100 %	PERCENT
admet-514	13	1	24 hours	TIME
admet-514	16	1	1	CARDINAL
admet-514	17	1	2,3	CARDINAL
admet-514	19	1	4	CARDINAL
admet-514	20	1	5	CARDINAL
admet-514	21	1	third	ORDINAL
admet-514	21	2	fourth	ORDINAL
admet-514	21	3	6	CARDINAL
admet-514	22	1	the http://www.pub.iapchem.org/ojs/index.php/admet/index mailto:r.honeywell@vumc.nl admet &	ORG
admet-514	22	2	6(3	CARDINAL
admet-514	22	3	2018	DATE
admet-514	22	4	258	CARDINAL
admet-514	22	5	10.5599/admet.514 259	QUANTITY
admet-514	23	1	5	CARDINAL
admet-514	24	1	8	CARDINAL
admet-514	26	1	98-100 %	PERCENT
admet-514	29	1	four	CARDINAL
admet-514	29	2	11	CARDINAL
admet-514	32	1	12	CARDINAL
admet-514	33	1	six	CARDINAL
admet-514	34	1	six	CARDINAL
admet-514	34	2	fda	ORG
admet-514	35	1	first	ORDINAL
admet-514	36	1	37 °	QUANTITY
admet-514	36	2	5 %	PERCENT
admet-514	36	3	100 %	PERCENT
admet-514	36	4	10 %	PERCENT
admet-514	36	5	20 mm	QUANTITY
admet-514	36	6	13	CARDINAL
admet-514	37	1	6 ml	QUANTITY
admet-514	37	2	1 %	PERCENT
admet-514	37	3	25	CARDINAL
admet-514	38	1	72 hours	TIME
admet-514	38	2	3-5x106	CARDINAL
admet-514	39	1	10	CARDINAL
admet-514	39	2	1 µm	QUANTITY
admet-514	39	3	2 and 24 hours	TIME
admet-514	40	1	three	CARDINAL
admet-514	40	2	10 ml	QUANTITY
admet-514	40	3	pbs	ORG
admet-514	41	1	500	CARDINAL
admet-514	41	2	about 5-10 minutes	TIME
admet-514	41	3	37 °	QUANTITY
admet-514	41	4	5 %	PERCENT
admet-514	41	5	100 %	PERCENT
admet-514	42	1	1.5 ml	QUANTITY
admet-514	43	1	200	CARDINAL
admet-514	46	1	four	CARDINAL
admet-514	47	1	13	CARDINAL
admet-514	48	1	richard honeywell	PERSON
admet-514	48	2	al. admet	ORG
admet-514	48	3	6(3	CARDINAL
admet-514	48	4	2018	DATE
admet-514	48	5	258	CARDINAL
admet-514	49	1	100-300	QUANTITY
admet-514	49	2	10 minutes	TIME
admet-514	49	3	4 °	QUANTITY
admet-514	50	1	2 ml	QUANTITY
admet-514	50	2	5 minutes	TIME
admet-514	50	3	4 °	QUANTITY
admet-514	50	4	100-300	QUANTITY
admet-514	50	5	4 °	QUANTITY
admet-514	50	6	10 minutes	TIME
admet-514	52	1	4	CARDINAL
admet-514	53	1	1 ml	QUANTITY
admet-514	53	2	5	CARDINAL
admet-514	53	3	10 minutes	TIME
admet-514	53	4	4 °	QUANTITY
admet-514	53	5	500-1000	QUANTITY
admet-514	53	6	4 °	QUANTITY
admet-514	53	7	10 minutes	TIME
admet-514	54	1	(fraction 1	CARDINAL
admet-514	54	2	-80 °	QUANTITY
admet-514	55	1	1 ml	QUANTITY
admet-514	55	2	5	CARDINAL
admet-514	55	3	30 minutes	TIME
admet-514	55	4	4 °	QUANTITY
admet-514	55	5	5000-6000	QUANTITY
admet-514	55	6	4 °	QUANTITY
admet-514	55	7	10 minutes	TIME
admet-514	56	1	2	CARDINAL
admet-514	56	2	-80°	QUANTITY
admet-514	57	1	500	CARDINAL
admet-514	57	2	5	CARDINAL
admet-514	57	3	1.5	CARDINAL
admet-514	57	4	10 minutes	TIME
admet-514	57	5	4 °	QUANTITY
admet-514	57	6	6800	CARDINAL
admet-514	57	7	4 °	QUANTITY
admet-514	57	8	10 minutes	TIME
admet-514	58	1	(fraction 3	CARDINAL
admet-514	58	2	-80 °	QUANTITY
admet-514	59	1	500	CARDINAL
admet-514	59	2	5	CARDINAL
admet-514	59	3	(fraction 4	CARDINAL
admet-514	59	4	-80 °	QUANTITY
admet-514	61	1	20	CARDINAL
admet-514	61	2	96	CARDINAL
admet-514	61	3	80	CARDINAL
admet-514	62	1	10 minutes	TIME
admet-514	63	1	96	CARDINAL
admet-514	63	2	1500	CARDINAL
admet-514	63	3	4 °	QUANTITY
admet-514	63	4	10 minutes	TIME
admet-514	64	1	50	CARDINAL
admet-514	64	2	96	CARDINAL
admet-514	65	1	1	CARDINAL
admet-514	66	1	0.578	CARDINAL
admet-514	66	2	375 ml	QUANTITY
admet-514	66	3	125 ml	QUANTITY
admet-514	66	4	0.1 %	PERCENT
admet-514	66	5	1000 ml	QUANTITY
admet-514	66	6	7.8	CARDINAL
admet-514	66	7	350	CARDINAL
admet-514	66	8	0.2 µm	CARDINAL
admet-514	66	9	10 minutes	TIME
admet-514	67	1	3	CARDINAL
admet-514	67	2	100x2 mm	QUANTITY
admet-514	67	3	3	CARDINAL
admet-514	71	1	2 hour	TIME
admet-514	71	2	24 hour	TIME
admet-514	71	3	24 hour	TIME
admet-514	72	1	6(3	CARDINAL
admet-514	72	2	2018	DATE
admet-514	72	3	258	CARDINAL
admet-514	72	4	10.5599/admet.514 261	QUANTITY
admet-514	73	1	sunitinib	PERSON
admet-514	74	1	sunitinib	PERSON
admet-514	75	1	2 hours sunitinib	TIME
admet-514	75	2	57.5 %	PERCENT
admet-514	75	3	42.1 %	PERCENT
admet-514	76	1	24 hours	TIME
admet-514	76	2	3.9 fold	CARDINAL
admet-514	76	3	1	CARDINAL
admet-514	76	4	2	CARDINAL
admet-514	76	5	1	CARDINAL
admet-514	77	1	1	CARDINAL
admet-514	77	2	6	CARDINAL
admet-514	77	3	hours	TIME
admet-514	77	4	sunitinib crizotinib erlotinib	PERSON
admet-514	77	5	gefitinib sorafenib dasatinib cytosolic fraction	PERSON
admet-514	77	6	1	CARDINAL
admet-514	77	7	2	CARDINAL
admet-514	77	8	58.3	CARDINAL
admet-514	77	9	38.8	CARDINAL
admet-514	77	10	24 56.6	QUANTITY
admet-514	77	11	0.0 55.6	CARDINAL
admet-514	77	12	2	CARDINAL
admet-514	77	13	2	CARDINAL
admet-514	77	14	3	CARDINAL
admet-514	77	15	2	CARDINAL
admet-514	77	16	24 2.7	CARDINAL
admet-514	77	17	0.0 11.0 13.9 0.0	QUANTITY
admet-514	77	18	4	CARDINAL
admet-514	77	19	2	CARDINAL
admet-514	77	20	100.0	CARDINAL
admet-514	77	21	2.8	CARDINAL
admet-514	77	22	25.7 16.5	CARDINAL
admet-514	77	23	2	CARDINAL
admet-514	77	24	24	CARDINAL
admet-514	77	25	2	CARDINAL
admet-514	77	26	6	CARDINAL
admet-514	77	27	2 hours 24 hours	TIME
admet-514	77	28	25692.8	CARDINAL
admet-514	77	29	5581.4	CARDINAL
admet-514	77	30	314.9 88.4	QUANTITY
admet-514	77	31	1572.8	CARDINAL
admet-514	77	32	462.9	CARDINAL
admet-514	77	33	2056.2	CARDINAL
admet-514	77	34	267.1	CARDINAL
admet-514	77	35	244.4 97.1	CARDINAL
admet-514	78	1	15 %	PERCENT
admet-514	79	1	2 hours	TIME
admet-514	79	2	58.3 %	PERCENT
admet-514	79	3	41.7 %	PERCENT
admet-514	80	1	24 hours	TIME
admet-514	80	2	4.5-fold	CARDINAL
admet-514	81	1	one	CARDINAL
admet-514	81	2	tki	ORG
admet-514	81	3	1	CARDINAL
admet-514	82	1	2 hours	TIME
admet-514	83	1	24 hours	TIME
admet-514	83	2	20-fold	CARDINAL
admet-514	84	1	2 and 24 hours	TIME
admet-514	84	2	1	CARDINAL
admet-514	85	1	2 hours	TIME
admet-514	85	2	38.8 %	PERCENT
admet-514	85	3	richard honeywell	PERSON
admet-514	85	4	al. admet	ORG
admet-514	85	5	6(3	CARDINAL
admet-514	85	6	2018	DATE
admet-514	85	7	258	CARDINAL
admet-514	85	8	44.4 %	PERCENT
admet-514	85	9	16.8 %	PERCENT
admet-514	85	10	24 hours	TIME
admet-514	86	1	5 7	DATE
admet-514	87	1	5 0 %	PERCENT
admet-514	89	1	4 2	CARDINAL
admet-514	89	2	1 0 %	PERCENT
admet-514	95	1	4 0 %	PERCENT
admet-514	101	1	2 4	DATE
admet-514	107	1	o	DATE
admet-514	108	1	o	DATE
admet-514	108	2	4 0	DATE
admet-514	109	1	2 0 %	PERCENT
admet-514	109	2	7 0 %	PERCENT
admet-514	115	1	5 6	DATE
admet-514	115	2	6 0 %	PERCENT
admet-514	118	1	0 0 %	PERCENT
admet-514	122	1	2 4 h o	DATE
admet-514	126	1	2 7	DATE
admet-514	127	1	9 0 %	PERCENT
admet-514	128	1	5 0 %	PERCENT
admet-514	131	1	6 0 %	PERCENT
admet-514	133	1	o	DATE
admet-514	133	2	1	CARDINAL
admet-514	133	3	2 and 24 hours	TIME
admet-514	133	4	10 μm	CARDINAL
admet-514	133	5	1	CARDINAL
admet-514	133	6	1	CARDINAL
admet-514	134	1	two hours	TIME
admet-514	134	2	84.7 %	PERCENT
admet-514	134	3	15.3 %	PERCENT
admet-514	135	1	24 hours	TIME
admet-514	135	2	9.9-fold	CARDINAL
admet-514	135	3	2	CARDINAL
admet-514	135	4	60.4%	PERCENT
admet-514	135	5	25.7 %	PERCENT
admet-514	135	6	13.9 %	PERCENT
admet-514	136	1	two hours	TIME
admet-514	136	2	1	CARDINAL
admet-514	136	3	1	CARDINAL
admet-514	137	1	6(3	CARDINAL
admet-514	137	2	2018	DATE
admet-514	137	3	258	CARDINAL
admet-514	137	4	10.5599/admet.514 263	QUANTITY
admet-514	137	5	24 hours	TIME
admet-514	138	1	27.9 %	PERCENT
admet-514	138	2	16.5 %	PERCENT
admet-514	140	1	2	CARDINAL
admet-514	141	1	3.9-fold	CARDINAL
admet-514	141	2	2 to 24 hours	TIME
admet-514	141	3	24 hours	TIME
admet-514	141	4	14	CARDINAL
admet-514	142	1	4.5-fold	CARDINAL
admet-514	142	2	24 hours	TIME
admet-514	143	1	24 hours	TIME
admet-514	143	2	5.3 %	PERCENT
admet-514	143	3	2 hours	TIME
admet-514	144	1	2 to 24 hours	TIME
admet-514	145	1	five	CARDINAL
admet-514	145	2	24 hours	TIME
admet-514	145	3	2 hours	TIME
admet-514	147	1	2	CARDINAL
admet-514	147	2	less than 0.4	CARDINAL
admet-514	147	3	0.206538	CARDINAL
admet-514	147	4	0.154453	CARDINAL
admet-514	147	5	0.389155	CARDINAL
admet-514	147	6	3	CARDINAL
admet-514	147	7	15	CARDINAL
admet-514	152	1	sunitinib	PERSON
admet-514	152	2	90%	PERCENT
admet-514	155	1	3	CARDINAL
admet-514	156	1	crizotinib dasatinib	PERSON
admet-514	156	2	gefitinib sorafenib sunitinib crizotinib	PERSON
admet-514	156	3	0.231458	CARDINAL
admet-514	156	4	0.196302	CARDINAL
admet-514	156	5	0.285714	CARDINAL
admet-514	157	1	richard honeywell et al	PERSON
admet-514	157	2	6(3	CARDINAL
admet-514	157	3	2018	DATE
admet-514	157	4	258	CARDINAL
admet-514	157	5	ho dasatinib	PERSON
admet-514	157	6	487.16	CARDINAL
admet-514	157	7	488.01	CARDINAL
admet-514	157	8	96%	PERCENT
admet-514	157	9	gibbs	ORG
admet-514	157	10	836.07	CARDINAL
admet-514	157	11	5.06 n nh2	QUANTITY
admet-514	159	1	3.39	CARDINAL
admet-514	159	2	449.12	CARDINAL
admet-514	159	3	450.34	CARDINAL
admet-514	160	1	90%	PERCENT
admet-514	160	2	393.17	CARDINAL
admet-514	160	3	393.44	CARDINAL
admet-514	160	4	473.87	CARDINAL
admet-514	160	5	3.3	CARDINAL
admet-514	160	6	hn n n	ORG
admet-514	160	7	o	DATE
admet-514	160	8	446.15	CARDINAL
admet-514	160	9	446.9	CARDINAL
admet-514	160	10	313.35	CARDINAL
admet-514	160	11	3.87	CARDINAL
admet-514	160	12	398.21	CARDINAL
admet-514	161	1	398.47	CARDINAL
admet-514	162	1	464.09	CARDINAL
admet-514	163	1	464.82	CARDINAL
admet-514	163	2	2.03	CARDINAL
admet-514	163	3	gibbs	PERSON
admet-514	164	1	3.76	CARDINAL
admet-514	164	2	2	CARDINAL
admet-514	165	1	six	CARDINAL
admet-514	167	1	17,18	CARDINAL
admet-514	168	1	19	CARDINAL
admet-514	169	1	13,20,21	CARDINAL
admet-514	170	1	sorafenib	PERSON
admet-514	171	1	22,23	CARDINAL
admet-514	174	1	bcr-abl	ORG
admet-514	174	2	1	CARDINAL
admet-514	175	1	6(3	CARDINAL
admet-514	175	2	2018	DATE
admet-514	175	3	258	CARDINAL
admet-514	175	4	10.5599/admet.514 265	QUANTITY
admet-514	177	1	six	CARDINAL
admet-514	178	1	10	CARDINAL
admet-514	180	1	1	CARDINAL
admet-514	180	2	f. broekman	PERSON
admet-514	180	3	e. giovannetti	PERSON
admet-514	180	4	g.j. peters	PERSON
admet-514	182	1	j. clin	PERSON
admet-514	183	1	oncol.	DATE
admet-514	184	1	2 (2011	DATE
admet-514	185	1	2	CARDINAL
admet-514	185	2	l. verlingue	GPE
admet-514	185	3	n. cozic	PERSON
admet-514	185	4	m. faron	PERSON
admet-514	185	5	p. burtin	PERSON
admet-514	185	6	boige	GPE
admet-514	185	7	a. hollebecque	ORG
admet-514	185	8	d. malka	PERSON
admet-514	186	1	second	ORDINAL
admet-514	187	1	2017	CARDINAL
admet-514	187	2	114–128	CARDINAL
admet-514	188	1	3	CARDINAL
admet-514	188	2	t.e. nielsen	PERSON
admet-514	188	3	m.h. clausen	PERSON
admet-514	189	1	fda	ORG
admet-514	190	1	36	CARDINAL
admet-514	190	2	422–439	CARDINAL
admet-514	191	1	4	CARDINAL
admet-514	191	2	g. i. owen	PERSON
admet-514	191	3	i. retamal	PERSON
admet-514	191	4	m. garrido	PERSON
admet-514	193	1	26	CARDINAL
admet-514	193	2	2017	CARDINAL
admet-514	193	3	1007–1017	CARDINAL
admet-514	194	1	5	CARDINAL
admet-514	194	2	c.g. da silva	PERSON
admet-514	194	3	r. j. honeywell	PERSON
admet-514	194	4	h. dekker	PERSON
admet-514	194	5	g. j. peters	PERSON
admet-514	196	1	opin	PERSON
admet-514	197	1	drug metab	PERSON
admet-514	199	1	11	CARDINAL
admet-514	199	2	703	CARDINAL
admet-514	200	1	6	CARDINAL
admet-514	200	2	n. van der steen	PERSON
admet-514	200	3	c. caparello	PERSON
admet-514	200	4	c. rolfo	PERSON
admet-514	200	5	g.j. peters	PERSON
admet-514	200	6	e. giovannetti	PERSON
admet-514	202	1	9 (	PERCENT
admet-514	202	2	6065–6074	CARDINAL
admet-514	203	1	7	CARDINAL
admet-514	203	2	broxterman	PERSON
admet-514	203	3	m. labots	PERSON
admet-514	203	4	r.r. de haas	PERSON
admet-514	203	5	h. dekker	PERSON
admet-514	203	6	r.j. honeywell	PERSON
admet-514	203	7	m.a.	PERSON
admet-514	203	8	rudek	PERSON
admet-514	203	9	l.v. beerepoot	PERSON
admet-514	203	10	r.j. musetrs	PERSON
admet-514	203	11	g. jansen	PERSON
admet-514	203	12	a.w. griffioen	PERSON
admet-514	203	13	y.g.	GPE
admet-514	203	14	assaraf	GPE
admet-514	203	15	r. pili	PERSON
admet-514	203	16	g.j. peters	PERSON
admet-514	203	17	verheul	PERSON
admet-514	205	1	clin	PERSON
admet-514	207	1	17 (2011) 7337-7346	DATE
admet-514	208	1	8	CARDINAL
admet-514	208	2	m. labots	PERSON
admet-514	208	3	h. dekker	PERSON
admet-514	208	4	e. galvani	PERSON
admet-514	208	5	j.s.w	PERSON
admet-514	208	6	lind	PERSON
admet-514	208	7	r. sciarillo	PERSON
admet-514	208	8	r. honeywell	PERSON
admet-514	208	9	e.f. smit	GPE
admet-514	208	10	verheul	PERSON
admet-514	208	11	g.j. peters	PERSON
admet-514	210	1	curr	PERSON
admet-514	213	1	2013	DATE
admet-514	214	1	927–939	CARDINAL
admet-514	215	1	9	CARDINAL
admet-514	215	2	van erp	ORG
admet-514	215	3	h. gelderblom	PERSON
admet-514	215	4	guchelaar	PERSON
admet-514	217	1	35	CARDINAL
admet-514	217	2	2009	DATE
admet-514	217	3	692–706	DATE
admet-514	218	1	10	CARDINAL
admet-514	218	2	k. valko.	PERSON
admet-514	220	1	european	NORP
admet-514	220	2	2010	DATE
admet-514	221	1	11	CARDINAL
admet-514	221	2	k. smid	PERSON
admet-514	221	3	n. losekoot	PERSON
admet-514	221	4	r. honeywell	PERSON
admet-514	221	5	verheul	PERSON
admet-514	221	6	f. mihren	PERSON
admet-514	221	7	m.l. sandvold	GPE
admet-514	221	8	g.j. peters	PERSON
admet-514	223	1	30	CARDINAL
admet-514	223	2	2012	DATE
admet-514	223	3	1908–1916	DATE
admet-514	224	1	12	CARDINAL
admet-514	224	2	honeywell	ORG
admet-514	224	3	d. sarkisjan	GPE
admet-514	224	4	i. kathmann	PERSON
admet-514	224	5	m.h. kristensen	PERSON
admet-514	224	6	g.j. peters	PERSON
admet-514	226	1	nucleosides	PERSON
admet-514	226	2	35	CARDINAL
admet-514	226	3	2016	CARDINAL
admet-514	226	4	652	CARDINAL
admet-514	227	1	13	CARDINAL
admet-514	227	2	r. honeywell	PERSON
admet-514	227	3	c. fatmawati	PERSON
admet-514	227	4	m. buddha	PERSON
admet-514	227	5	s. hitzerd	PERSON
admet-514	227	6	i. kathman	PERSON
admet-514	227	7	g.j. peters	PERSON
admet-514	229	1	3	CARDINAL
admet-514	230	1	14	CARDINAL
admet-514	230	2	c. adessi	PERSON
admet-514	230	3	a. giraudel	PERSON
admet-514	230	4	j. lunardi	PERSON
admet-514	232	1	18 (1997	DATE
admet-514	233	1	307–316	CARDINAL
admet-514	234	1	richard honeywell et al	PERSON
admet-514	234	2	6(3	CARDINAL
admet-514	234	3	2018	DATE
admet-514	234	4	258	CARDINAL
admet-514	234	5	15	CARDINAL
admet-514	234	6	backman	PERSON
admet-514	234	7	t. girke	PERSON
admet-514	237	1	39 (2011	DATE
admet-514	238	1	16	CARDINAL
admet-514	238	2	k. azijli	PERSON
admet-514	238	3	k.j.	GPE
admet-514	238	4	h.m.	GPE
admet-514	238	5	verheul	PERSON
admet-514	240	1	j. kidney	PERSON
admet-514	240	2	2	CARDINAL
admet-514	240	3	2016	CARDINAL
admet-514	240	4	195	CARDINAL
admet-514	241	1	17	CARDINAL
admet-514	241	2	y.g.	GPE
admet-514	245	1	24	DATE
admet-514	245	2	2016	CARDINAL
admet-514	245	3	23–33	CARDINAL
admet-514	246	1	18	CARDINAL
admet-514	246	2	y.g.	GPE
admet-514	248	1	6 (	PERCENT
admet-514	248	2	2015	CARDINAL
admet-514	248	3	1143–1156	CARDINAL
admet-514	249	1	19	CARDINAL
admet-514	249	2	honeywell	ORG
admet-514	249	3	s. hitzerd	PERSON
admet-514	249	4	i. kathmann	PERSON
admet-514	249	5	g. j. peters	PERSON
admet-514	250	1	six	CARDINAL
admet-514	251	1	4	CARDINAL
admet-514	251	2	2016	CARDINAL
admet-514	251	3	23	CARDINAL
admet-514	252	1	20	CARDINAL
admet-514	252	2	e. schaeffeler	PERSON
admet-514	252	3	a. sparreboom	PERSON
admet-514	252	4	s. laufer	PERSON
admet-514	252	5	m. schwab	PERSON
admet-514	252	6	a.t.	PERSON
admet-514	252	7	nies	PERSON
admet-514	254	1	37	DATE
admet-514	254	2	2016	CARDINAL
admet-514	254	3	904–932	CARDINAL
admet-514	255	1	21	CARDINAL
admet-514	255	2	m. galetti	PERSON
admet-514	255	3	c. fumarola	PERSON
admet-514	255	4	d. cretella	PERSON
admet-514	255	5	s. la monica	PERSON
admet-514	255	6	m. bonelli	PERSON
admet-514	255	7	a. cavazzoni	PERSON
admet-514	255	8	f. saccani	PERSON
admet-514	255	9	c. caffarra	PERSON
admet-514	255	10	r. andreoli	PERSON
admet-514	255	11	a. mutti	PERSON
admet-514	255	12	m. tiseo	PERSON
admet-514	255	13	a. ardizzoni	PERSON
admet-514	255	14	r.r	GPE
admet-514	255	15	alfieri	PERSON
admet-514	256	1	abcg2	GPE
admet-514	257	1	plos	ORG
admet-514	257	2	one 10 (2015	CARDINAL
admet-514	258	1	22	CARDINAL
admet-514	258	2	e.i. zimmerman	ORG
admet-514	258	3	s. hu	PERSON
admet-514	258	4	j.l. roberts	PERSON
admet-514	258	5	a.a. gibbson	GPE
admet-514	258	6	l. li	PERSON
admet-514	258	7	a. sparreboom	PERSON
admet-514	258	8	baker	PERSON
admet-514	260	1	clin	PERSON
admet-514	262	1	19	CARDINAL
admet-514	262	2	2013) 1458–66	DATE
admet-514	263	1	23	CARDINAL
admet-514	263	2	s. hu	PERSON
admet-514	265	1	clin	PERSON
admet-514	268	1	85	CARDINAL
admet-514	268	2	2009	DATE
admet-514	268	3	208–11	CARDINAL
admet-514	269	1	2018	DATE
admet-514	270	1	iapc	ORG
admet-514	270	2	zagreb	GPE
admet-514	270	3	croatia	GPE
admet-514	271	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-514	271	2	http://creativecommons.org/licenses/by/3.0/	ORG